Target molecular treatment markers in Intrahepatic Cholangiocarcinoma based on Chinese population
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (9) , 153116
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for the Central Universities (YG1805049021414380408)
- National Natural Science Foundation (81802394)
This publication has 18 references indexed in Scilit:
- Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for InterventionClinical Cancer Research, 2018
- Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced CholangiocarcinomaJournal of Clinical Oncology, 2018
- Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular ProfilesCell Reports, 2017
- Pathology of intrahepatic cholangiocarcinomaHepatoBiliary Surgery and Nutrition, 2017
- Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinomaHuman Pathology, 2014
- Pathogenesis, Diagnosis, and Management of CholangiocarcinomaGastroenterology, 2013
- Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinomaHepatology, 2013
- Risk factors for cholangiocarcinomaHepatology, 2011
- Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancerExpert Review of Gastroenterology & Hepatology, 2010
- CholangiocarcinomaThe Lancet, 2005